Back to top
more

UCB (UCBJF)

(Delayed Data from OTC)

$128.50 USD

128.50
98

-0.23 (-0.18%)

Updated Apr 24, 2024 11:13 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for UCBJF

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for UCB SA falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents -99,999 1,336 1,817 1,880 1,631
Receivables NA 1,190 1,526 1,233 1,130
Notes Receivable NA 0 0 0 0
Inventories NA 956 1,039 976 874
Other Current Assets NA 0 7 3 56
Total Current Assets NA 3,481 4,389 4,092 3,690
Net Property & Equipment NA 1,511 1,508 1,182 941
Investments & Advances NA 230 238 183 196
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 797 819 691 978
Intangibles NA 10,700 9,858 9,066 6,606
Deposits & Other Assets NA 0 0 0 0
Total Assets NA 16,719 16,812 15,214 12,411
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable NA 0 0 0 0
Accounts Payable NA 2,626 3,023 2,442 2,079
Current Portion Long-Term Debt NA 276 65 492 343
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 53 37 90 91
Other Current Liabilities NA 325 217 190 169
Total Current Liabilities NA 3,279 3,341 3,214 2,681
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 397 226 192 57
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 2,779 2,447 2,646 1,092
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 713 877 856 730
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 7,169 6,890 6,907 4,561
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 2,754 3,093 2,986 2,928
Capital Surplus NA 0 0 0 0
Retained Earnings NA 6,790 7,446 6,240 5,560
Other Equity NA 388 -150 -471 -215
Treasury Stock NA 382 467 449 422
Total Shareholder's Equity NA 9,550 9,921 8,307 7,850
Total Liabilities & Shareholder's Equity NA 16,719 16,812 15,214 12,411
Total Common Equity 0 9,550 9,921 8,307 7,850
Shares Outstanding NA 189.00 189.00 194.50 194.50
Book Value Per Share 0.00 50.53 52.49 42.71 40.36

Fiscal Year End for UCB SA falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 -99,999 -99,999 818 -99,999
Receivables NA NA NA 1,419 NA
Notes Receivable NA NA NA NA NA
Inventories NA NA NA 994 NA
Other Current Assets NA NA NA 41 NA
Total Current Assets NA NA NA 3,272 NA
Net Property & Equipment NA NA NA 1,656 NA
Investments & Advances NA NA NA 243 NA
Other Non-Current Assets NA NA NA NA NA
Deferred Charges NA NA NA 880 NA
Intangibles NA NA NA 10,721 NA
Deposits & Other Assets NA NA NA NA NA
Total Assets NA NA NA 16,773 NA
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA NA NA NA NA
Accounts Payable NA NA NA 2,240 NA
Current Portion Long-Term Debt NA NA NA 300 NA
Current Portion Capital Leases NA NA NA NA NA
Accrued Expenses NA NA NA NA NA
Income Taxes Payable NA NA NA 128 NA
Other Current Liabilities NA NA NA 220 NA
Total Current Liabilities NA NA NA 2,887 NA
Mortgages NA NA NA NA NA
Deferred Taxes/Income NA NA NA 387 NA
Convertible Debt NA NA NA NA NA
Long-Term Debt NA NA NA 2,858 NA
Non-Current Capital Leases NA NA NA NA NA
Other Non-Current Liabilities NA NA 781 NA
Minority Interest (Liabilities) NA NA NA NA NA
Total Liabilities NA NA NA 6,913 NA
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA NA NA NA NA
Common Stock (Par) NA NA NA 2,850 NA
Capital Surplus NA NA NA NA NA
Retained Earnings NA NA NA 7,072 NA
Other Equity NA NA NA 328 NA
Treasury Stock NA NA NA 390 NA
Total Shareholder's Equity NA NA NA 9,859 NA
Total Liabilities & Shareholder's Equity NA NA NA 16,773 NA
Total Common Equity 0 0 0 109,858 0
Shares Outstanding NA NA NA NA 189.00
Book Value Per Share 0.00 0.00 0.00 -1.10 0.00